LONGEVA.
··

SLU-PP-915: dosing and an honest frame

← Peptide dosage chart

Human schedule

Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.

SLU-PP-915 is an orally active ERR agonist (an "exercise mimetic") that is taken by mouth in studies; unlike SLU-PP-332 it does not require injection. The figures below are a generalized reference drawn from preclinical work (mice only), not human clinical data.

This is a concise reference to regimens described for adults; it is not an individual prescription.

Period / conditionDoseEscalation
Start (oral)1 mg per dayStarting dose
Titration1–2 mg per dayIncrease if needed
Upper reference in this scheduleup to 2–3 mg per day (may be split into 2 doses)Maximum in this schedule